par Van Den Bruel, Annick;Moreno Reyes, Mario Rodrigo 
;Bex, Marie;Daumerie, Ch;Glinoer, Daniel
Référence Clinical endocrinology, 68, 4, page (599-604)
Publication Publié, 2008-04
;Bex, Marie;Daumerie, Ch;Glinoer, Daniel Référence Clinical endocrinology, 68, 4, page (599-604)
Publication Publié, 2008-04
Article révisé par les pairs
| Résumé : | Objective: To assess approaches to patients with a potentially malignant thyroid nodule and patients with differentiated thyroid carcinoma and compare them with the European Consensus and Guidelines by the American Thyroid Association. Design: A survey of the 388 active members of the Belgian Thyroid Club. Methods: A questionnaire addressing the management of an index case and four clinical variations (including variations in the size of the tumour and histological type). The index case was a 40-year-old euthyroid woman with a 3-cm solitary thyroid nodule. Fine-needle aspiration (FNA) cytology showed cellular aspirates with numerous follicular cells and no colloid. Results: The overall response rate was 41%. For the index case, respondents favoured a right lobectomy. Variations in size and histopathology of the nodule altered the management. In the case of a papillary thyroid carcinoma (PTC) of 3 cm in diameter, a total thyroidectomy and prophylactic central lymph node dissection was preferred. After a lobectomy showing a 3.5-cm follicular thyroid carcinoma (FTC), completion surgery followed by radioiodine administration was the most frequent proposal. For the follow-up of the index case with a low-risk disease, determination of serum thyroglobulin (Tg) after recombinant human TSH (rhTSH) administration was considered by the majority of respondents. For the follow-up of a clinical variation with residual disease, immediate planning of a new treatment was (mistakenly) not considered by a majority of respondents. Conclusions: In most cases, respondents were in accordance with the guidelines, although there were some unexpected variations. © 2007 The Authors. |
